Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 30Breast 29CNS 6Genitourinary 5Gastrointestinal 4Other hematologic neoplasm 3Thoracic 1Other 1Gynecologic 1Dermatologic 1

Conditions

Obesity 218Neoplasms 73Breast Neoplasms 66Overweight 65Sexual Dysfunction, Physiological 51Motor Activity 43Polycystic Ovary Syndrome 42Weight Loss 32Mucositis 29Dyspnea 28Prostatic Neoplasms 22Multiple Endocrine Neoplasia Type 1 16Constipation 15Lung Neoplasms 14Endometrial Neoplasms 14Diabetes Mellitus 14Anxiety Disorders 14Sedentary Behavior 13Depression 13Sexual Dysfunctions, Psychological 12Cardiovascular Diseases 12Pain 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Fatigue 10Diabetes Mellitus, Type 2 10Colorectal Neoplasms 10Sexuality 9Obesity, Morbid 9Insulin Resistance 9Head and Neck Neoplasms 9

Interventions

Mindfulness-Based Stress Reduction 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Cognitive Dysfunction × Other × Clear all
NCT02518308 2019-11-15

Mindfulness Intervention in Reducing Anxiety in Patients Who Have Been Treated for Gynecologic Cancer

University of Wisconsin, Madison

Phase NA Completed
38 enrolled
Other

Anxiety Disorders, Depression, Fatigue, Pain, Sexual Dysfunction, Physiological, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡